Back to search
FDAFDA · Food and drugs·Recall number Z-0877-2022

Panther Fusion GBS Assay Cartridges 96 Tests, Catalog Number: PRD-04484. in vitro diagnostic test for group b streptococcus.

Published April 13, 2022 · Recall initiated: March 18, 2022

Summary

FDA records medical device Class II recall Z-0877-2022, published April 13, 2022 and initiated March 18, 2022. Recalling firm: Hologic, Inc; Status: Ongoing; Reported quantity: 2061; Lot: UDI: 15420045510890, Lot numbers: 274954, 284599, 296991, 300796, 309230, 309353. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Samples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hologic, Inc
Distributor
US: TX, TN, NY, NV, IN, AR, CA, CT, IL, NH, PA, WA, FL, OR, WV, VA, UT, MA, NJ, MI, PR OUS: CA
Lot
UDI: 15420045510890, Lot numbers: 274954, 284599, 296991, 300796, 309230, 309353
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Panther Fusion GBS Assay Cartridges 96 Tests, Catalog Number: PRD-04484. in vitro diagnostic test for group b streptococcus. recalled?

Yes. FDA published recall Z-0877-2022 on April 13, 2022. Reported hazard: Samples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter